Abstract
The proportion of elderly persons (65 years or older) has increased in most countries during the last few decades, and will increase further in the coming years. Annual age-standardised cancer incidence rates per 100 000 elderly persons (1988 to 1992) were calculated based on data from cancer registries in 51 countries in 5 continents kept by the International Agency for Research on Cancer (IARC) and International Association of Cancer Registries (IACR). The proportions of all cancers among elderly men and women were 61 and 56% respectively. All cancers combined (except nonmelanoma skin cancer) were, based on the standardised rates, almost 7-fold more frequent among elderly men (2158 per 100 000 person-years), and around 4-fold more frequent among elderly women (1192 per 100 000 person-years) than among younger persons (30 to 64 years old). However, large variations exist between different cancer sites. Contrary to the pattern in younger age groups, in which annual cancer rates are almost equally distributed among the 2 genders, elderly men have an almost double cancer incidence rate compared with elderly women. For all major specific cancer sites except testicular cancer, the incidence rate is significantly higher among the elderly than among any groups of younger and middle-aged persons. Among elderly men, cancer of the prostate (451 per 100 000), the lung (449 per 100 000) and the colon (176 per 100 000) make up around half of all diagnosed cancers. Prostate cancer is around 22 times more frequent among elderly men than among younger men. The corresponding most frequent cancers among elderly women, making up 48% of all malignant cancers, are breast (248 per 100 000), colon (133 per 100 000), lung (118 per 100 000) and stomach cancer (75 per 100 000). For most cancers, marked geographical variations in incidence rates are found among the elderly, reflecting socioeconomic differences, particularly between the developing and the developed countries. In contrast with other major causes of death among the elderly, cancer incidence and mortality have not in general declined, indicating that primary prevention (especially cessation of tobacco smoking) remains a most valuable approach to decrease mortality; for most of the major cancers (prostate, colon, breast) the causes remain almost unknown. Thus, research into potential causes is urgently needed for future prevention. Since the mortality rates for female cancer in general are declining, and since the incidence is increasing more steeply than the mortality among the men, the number of living elderly ever diagnosed with a cancer will further increase during the next years. Therefore, it is important to emphasise the increasing need for research into the prevention of cancer and the planning of treatment and care in the elderly.
Similar content being viewed by others
References
Doll R. The age distribution of cancer: implications for models on carcinogenesis. J R Stat Soc Ser 1971; 134: 133–55
Cook P, Doll R, Fellingham SA. A mathematical model for the age distribution on cancer in man. Int J Cancer 1969; 4: 93–112
Yancik R, Ries LA. Cancer in older persons. Cancer 1994; 74: 1995–2003
Smith DWE. Circulatory disease mortality in the elderly. Epidemiology 1997; 8: 501–4
Muir CS, Nectoux J. International patterns of cancer. In: Schottenfeld D, Fraumeni Jr JF, editors. Cancer epidemiology and prevention. New York: Oxford University Press, 1996: 141–67
Wingo PA, Ries LAG, Rosenberg HM, et al. Cancer incidence and mortality, 1973–95. A report card for the US. Cancer 1998; 82: 1197–207
Hoel DG, Davis DL, Miller AB, et al. Trends in cancer mortality in 15 industrialized countries, 1969–1986. J Natl Cancer Inst 1992; 84: 313–20
Coebergh JW. Significant trends in cancer in the elderly. Eur J Cancer 1996; 32a: 569–71
Butler RN. Population aging and health. BMJ 1997; 315: 1082–4
Parkin DM, Whelan SL, Ferlay J, et al. IARC scientific publications: cancer incidence in five continents. Vol. VII. Lyon: International Agency for Research on Cancer (IARC), 1997
World Health Organization. International classification of diseases. 9th Rev. Geneva: WHO, 1977
Doll R, Payne P, Waterhouse J. Cancer incidence in five continents. Berlin: Springer-Verlag, 1966
Segi M. Cancer mortality for selected sites in 24 countries (1950–57). Sendai: Tohoku University of Public Health, 1960
Jensen OM, Parkin DM, MacLennan R, et al. IARC scientific publications: cancer registration principles and methods. Lyon: International Agency for Research on Cancer (IARC), 1991
Balducci L, Pow Sang J, Friedland J, et al. Prostate cancer. Clin Geriatr Med 1997; 13: 283–306
Merrill RM, Brawley OW Prostate cancer incidence and mortality rates among white and black men. Epidemiology 1997; 8: 126–31
Merrill RM, Weed DL, Feuer EJ. The lifetime risk of developing prostate cancer in white and black men. Cancer Epidemiol Biomarkers Prev 1997; 6: 763–8
Potosky AL, Kessler L, Gridley G, et al. Rise in prostatic cancer incidence associated with increase use of transurethral resection. J Natl Cancer Inst 1990; 82: 1624–8
Rohr LR. Incidental adenocarcinoma in transurethral resections of the prostate: partial versus complete microscopic examination. Am J Surg Pathol 1987; 11: 53–8
Potosky AL, Miller BA, Albertsen PC, et al. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995; 273: 548–52
Mettlin C. Changes in patterns of prostate cancer care in the United States: results of American College of Surgeons Commission on Cancer studies, 1974–1993. Prostate 1997; 32: 221–6
Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594–606
Adami HO, Adams G, Boyle P, et al. Breast-cancer etiology. Int J Cancer 1990; Suppl. 5: 22–39
Boyle P, Leake R. Progress in understanding breast cancer: epidemiological and biological interactions. Breast Cancer Res Treat 1988; 11: 91–112
Kelsey JL, Berkowitz GS. Breast-cancer epidemiology. Cancer Res 1988; 48: 5615–23
Balducci L, Silliman RA, Baekey P. Breast cancer: an oncological perspective. Pt 1. In: Balducci L, Lyman GH, William BE, editors. Comprehensive geriaric oncology. Amsterdam: Harwood Academic Publishers, 1997: 629–60
Caplan LS. Disparities in breast cancer screening: is it ethical? Public Health Rev 1997; 25: 31–41
Trontell AE, Franey EW Use of mammography services by women aged >65 years enrolled in Medicare — United States, 1991–1993 [abstract]. JAMA 1995; 274: 1420
Hansen J, Olsen JH. Respiratory system: nasal cavities and sinuses, larynx, lung, pleura. Acta Pathol Microbiol Scand 1993; 100 Suppl. 33: 77–98
Doll R. Major epidemics of the 20th century from coronary thrombosis to AIDS. J R Stat Soc 1987; 150: 373–95
Levi F, Vecchia CL, Lucchini F, et al. Worldwide trends in cancer mortality in the eldery, 1955–1992. Eur J Cancer 1996; 32a: 652–72
McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 1980; 65: 1201–7
Potter JD, Slattery ML, Bostick RM, et al. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993; 15: 499–545
Sian MS. Diet and nutritional factors in the aetiology of colon cancer [review]. Anticancer Res 1987; 7: 293–300
van Loon AJ, Burg J, Goldbohm RA, et al. Differences in cancer incidence and mortality among socio-economic groups. Scand J Soc Med 1995; 23: 110–20
Williams J, Clifford C, Hopper J, et al. Socioeconomic status and cancer mortality and incidence in Melbourne. Eur J Cancer 1991; 27: 917–21
Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986; 8: 1–27
Cordle F. The use of epidemiology, scientific data, and regulatory authority to determinate risk factors in cancers of some organs of the digestive system: 5. stomach cancer. Regul Toxicol Pharmacol 1986; 6: 171–80
International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: hepatitis viruses. Lyon: International Agency for Research on Cancer (IARC), 1994; 1–286
Benhamiche AM, Faivre J, Tazi AM, et al. Time trends in diagnostic strategy, treatment, and prognosis of gastric cancer in the elderly: a population based study. Eur J Cancer Prev 1997; 6:71–7
Smith DWE. Cancer mortality at very old ages. Cancer 1996; 77: 1367–72
Stanta G, Campagner L, Cavallieri F, et al. Cancer of the oldest old: what we have learned from autopsy studies. Clin Geriatr Med 1997; 13: 55–68
Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1192–308
International Agency for Research on Cancer: IARC Monographs on the evaluation of carcinogenic risks to humans: tobacco smoking. Vol. 37. Lyon: International Agency for Research on Cancer (IARC), 1986
International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: schistosomes, liver flukes and heliobacter pylori. Lyon: International Agency for Research on Cancer (IARC), 1994; 1–270
Cameron HM, McGoogan E. A prospective study of 1152 hospital autopsies: I. inaccuracies in death certification. J Pathol 1981; 133: 273–83
Cameron HM, McGoogan E, Watson H. Necropsy: a yardstick for clinical diagnoses. BMJ 1980; 281: 985–8
Berrino F, Sant M, Verdecchia A, et al. IARC Scientific Publications: survival of cancer patients in Europe: the Eurocare study. Lyon: International Agency for Research on Cancer (IARC), 1995
Ries LAG, Hankey BF, Harras A, et al. Cancer incidence, mortality, and patient survival in the United States. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. New York: Oxford University Press, 1996: 168–91
Havlik RJ, Yancik R, Long S, et al. The National Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer 1994; 74: 2101–6
Yancik R, Havlik RJ, Wesley MN, et al. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol 1996; 6: 399–412
Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994; 120: 104–10
Kant AK, Glover C, Horm J, et al. Does cancer survival differ for older patients? Cancer 1992; 70: 2734–40
Samet J, Hunt WC, Key C, et al. Choice of cancer therapy varies with age of patient. JAMA 1986; 255: 3385–90
Mor V, Masterson Allen S, Goldberg RJ, et al. Relationship between age at diagnosis and treatments received by cancer patients. J Am Geriatr Soc 1985; 33: 585–9
Goodwin JS, Samet JM, Key CR, et al. Stage at diagnosis of cancer varies with the age of the patient. J Am Geriatr Soc 1986; 34: 20–6
Holmes FF, Weyandt T, Glazier J, et al. Fulminant Meningococcemia after splenectomy. JAMA 1981; 246: 1119–20
Samet JM, Hunt WC, Goodwin JS. Determinants of stage and size of cancer in the elderly New Mexicans: a population based study. Cancer 1990; 46: 1302–7
Doll R, Fraumeni Jr JF, Muir CS. Cancer surveys: trends in cancer incidence and mortalty. New York: Cold Spring Harbor Laboratory Press, 1994; 1–583
Polednak AP. Estimating the prevalence of cancer in the United States. Cancer 1997; 80: 136–41
Micheli A, Gatta G, Verdecchia A. Studying survival of cancer patients in different populations: its potential and role. Tumori 1997; 83: 3–8
National Board of Health. Sundhedsstatistikken: Cancer incidence i Denmark 1994. Copenhagen: The Danish National Board of Health, 1998; 1–96
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hansen, J. Common Cancers in the Elderly. Drugs & Aging 13, 467–478 (1998). https://doi.org/10.2165/00002512-199813060-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199813060-00005